Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Azacitidine × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 69 Myelodysplastic Syndromes 25 Leukemia, Myelomonocytic, Chronic 14 Leukemia 7 Myeloproliferative Disorders 6 Anemia, Refractory, with Excess of Blasts 5 Leukemia, Biphenotypic, Acute 4 Hematologic Neoplasms 4 Recurrence 3 Lymphoma, T-Cell, Peripheral 3 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma 2 Leukemia, Neutrophilic, Chronic 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Hematologic Diseases 2 GATA2 Deficiency 2 Thrombocytosis 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Myeloid 1 Sarcoma 1 Polycythemia Vera 1 Pathologic Complete Response 1

Interventions

Fulvestrant 56 Letrozole 52 Trastuzumab 46 Paclitaxel 43 pembrolizumab 39 Capecitabine 36 ribociclib 31 Tamoxifen 31 abemaciclib 30 Anastrozole 28 palbociclib 27 exemestane 25 pertuzumab 24 Radiotherapy 24 Cyclophosphamide 24 trastuzumab deruxtecan 23 olaparib 21 Surveys and Questionnaires 21 Specimen Handling 21 Magnetic Resonance Spectroscopy 21 Carboplatin 19 Biopsy 18 Blood Specimen Collection 15 Docetaxel 14 130-nm albumin-bound paclitaxel 14 eribulin 13 Radiation 12 giredestrant 11 Gonadotropin-Releasing Hormone 11 Gemcitabine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04891068 2026-01-14

BRE-04

University of Illinois at Chicago

Phase 2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡